Blood Test Offers Early Lung Cancer Detection

The development could facilitate the early assessment of recurrence risks, timely interventions, and more precise monitoring of lung cancer, potentially improving patient outcomes. Currently, the NeXT Personal test is available for clinical testing as part of an early access program at Personalis, and the next phase of research involves validating the findings in prospective cohorts, with the goal of making the test a routine clinical tool for specific patient groups.